Current status of therapeutic approaches to adult T-cell leukemia (Q35611770)

9 August 2017

1 reference

title

Current status of therapeutic approaches to adult T-cell leukemia (English)

1 reference

9 August 2017

Takayuki Ishikawa

1

1 reference

9 August 2017

1 November 2003

1 reference

International Journal of Hematology

9 August 2017

1 reference

9 August 2017

78

1 reference

9 August 2017

4

1 reference

9 August 2017

304-311

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02983554

9 August 2017

0 references

cites work

Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02983554

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02983554

Autologous stem cell transplantations for recurrent adult T cell leukaemia/lymphoma using highly purified CD34+ cells derived from cryopreserved peripheral blood stem cells

21 January 2018

1 reference

12 December 2020

Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.

1 reference

12 December 2020

Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin

1 reference

12 December 2020

Prognostic significance of multidrug resistance protein in adult T-cell leukemia.

1 reference

12 December 2020

Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation

1 reference

12 December 2020

Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells

1 reference

12 December 2020

Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells

1 reference

12 December 2020

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.

1 reference

12 December 2020

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

1 reference

12 December 2020

Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia

1 reference

12 December 2020

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

1 reference

12 December 2020

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

1 reference

12 December 2020

Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia.

1 reference

12 December 2020

Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.

1 reference

12 December 2020

Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia

1 reference

12 December 2020

Alemtuzumab in T-cell malignancies

1 reference

12 December 2020

Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.

1 reference

12 December 2020

A new classification of clinical stages of adult T-cell leukemia based on prognosis of the disease

1 reference

12 December 2020

Cyclosporin A withdrawal causes spontaneous remission of recurrent subcutaneous tumors after allogeneic peripheral blood stem cell transplantation for adult T-cell leukemia/lymphoma

1 reference

12 December 2020

An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support

1 reference

12 December 2020

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

1 reference

12 December 2020

Interferon-alpha therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma

1 reference

12 December 2020

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

12 December 2020

Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.

1 reference

12 December 2020

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

1 reference

12 December 2020

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

12 December 2020

Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia

1 reference

12 December 2020

Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma

1 reference

12 December 2020

Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia

1 reference

12 December 2020

CD30-positive lymphoma in human T-cell leukaemia virus type 1 carrier without monoclonal integration of HTLV-1.

1 reference

12 December 2020

The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group.

1 reference

12 December 2020

HTLV-I-associated myelopathy following allogeneic bone marrow transplantation

1 reference

12 December 2020

Successful allogeneic bone marrow transplantation in selected patients over 50 years of age--a single institution's experience

1 reference

12 December 2020

Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma

1 reference

12 December 2020

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases

1 reference

12 December 2020

Adult T-cell leukemia successfully treated with allogeneic bone marrow transplantation.

1 reference

12 December 2020

Variation in the clinical courses of adult T-cell leukemia

1 reference

12 December 2020

Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia.

1 reference

12 December 2020

Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.

1 reference

12 December 2020

Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.

1 reference

12 December 2020

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

1 reference

12 December 2020

Haematopoietic cell transplantation as immunotherapy

1 reference

12 December 2020

Adult T-cell leukemia: clinical and hematologic features of 16 cases

1 reference

12 December 2020

Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group

1 reference

12 December 2020

Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells

1 reference

12 December 2020

Expression of functional lung resistance--related protein predicts poor outcome in adult T-cell leukemia

1 reference

12 December 2020

Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).

1 reference

12 December 2020

A decade of progress in allogeneic hematopoietic cell transplantation: 1990-2000.

1 reference

12 December 2020

Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV-1 genotype.

1 reference

12 December 2020

Radiation therapy of adult T-cell leukemia

1 reference

12 December 2020

Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes

1 reference

12 December 2020

Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia

1 reference

12 December 2020

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

1 reference

12 December 2020

2'-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

12 December 2020

The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

1 reference

12 December 2020

Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL).

1 reference

12 December 2020

Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.

1 reference

12 December 2020

Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL).

1 reference

12 December 2020

Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.

1 reference

12 December 2020

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

12 December 2020

Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

12 December 2020

Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population

1 reference

12 December 2020

Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02983554

1 reference

9 August 2017

1 reference

PubMed ID

14686487